Lantheus Holdings, Inc. Announces Merger with Curium US Holdings LLC
Acquiring Company
Lantheus Holdings
Acquired Company
Curium
Bedford
ParisBiotechnologyHealth CareTherapeuticsManufacturingBiotechnologyHealth CareDescription
On August 3, 2026, Lantheus Holdings, Inc. and Curium US Holdings LLC announced the execution of a Merger Agreement. This agreement will facilitate the merger between Lantheus and Curium's parent company. Both companies aim to enhance their offerings in the nuclear medicine market.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Curium?
Curium was acquired by Lantheus Holdings, based in Bedford. The deal was reported on August 3, 2026. Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Lantheus Holdings is publicly traded (LNTH) and operates in Biotechnology.
When did Lantheus Holdings acquire Curium?
Lantheus Holdings's acquisition of Curium was reported on August 3, 2026. On August 3, 2026, Lantheus Holdings, Inc. and Curium US Holdings LLC announced the execution of a Merger Agreement. This agreement will facilitate the merger between Lantheus and Curium's parent company. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Curium do?
Curium is a world leader in nuclear medicine. We develop, manufacture, and distribute world-class radiopharmaceutical products to help patients around the globe. It is privately held, operating in Manufacturing, and is based in Paris.